Immunocytochemical Staining For the C‐Erbb‐2 Gene Product In Breast Aspirates: A Preliminary Report
- 1 August 1993
- journal article
- research article
- Published by Wiley in Cytopathology
- Vol. 4 (4) , 219-224
- https://doi.org/10.1111/j.1365-2303.1993.tb00091.x
Abstract
The results of the determination of c-erbB-2 gene expression by immunocytochemical staining of cytological aspirates, prepared by cytocentrifugation, have been compared with paraffin-embedded tissue sections from the same tumour. Our results show equivalent staining in 20/22 cases, with six cases being both scored positive and fourteen cases being both negative. Two samples gave conflicting results. One case was scored as being positive on the cytological aspirate, whereas in the tissue sections taken from the same tumour positive staining was only seen in areas of non-invasive intraduct carcinoma. This sample was scored as being negative. In another case, cytoplasmic staining with less than 50% of the cells showing any positivity was observed in the cytospin sample, with negative staining in the corresponding tissue section. We conclude that expression of c-erbB-2 immunostaining is detectable on cytological preparations prepared by cytocentrifugation but must be interpreted with caution in tumours which may have a large intraduct component or which give predominant cytoplasmic staining.Keywords
This publication has 11 references indexed in Scilit:
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancerBritish Journal of Cancer, 1992
- The long term prognostic significance of c-erbB-2 in primary breast cancerBritish Journal of Cancer, 1991
- The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancerBritish Journal of Cancer, 1991
- c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesBritish Journal of Cancer, 1991
- Rat monoclonal antibodies to the external domain of the product of the C‐erbB‐2 proto‐oncogeneInternational Journal of Cancer, 1990
- HER-2/neu oncogene protein and prognosis in breast cancer.Journal of Clinical Oncology, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancerInternational Journal of Cancer, 1988